Article
Polygenic risk and germline genetics for prostate cancer in Asians: Where do we stand?
Investigative and clinical urology - 1 Mar 2026
Song Sang Hun, Hong Sung Kyu
Abstract excerpt
Prostate cancer exhibits marked ethnic differences in genetic architecture. Although polygenic risk scores (PRS) and germline genetic testing have shown clinical utility in European populations, their applicability to Asian populations remains limited. This review synthesizes evidence published between 2020 and 2025 on PRS and germline genetics in Asian prostate cancer cohorts, focusing on Chinese, Japanese, and...
Topics
Join the communities discussing this publication.
